Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.55 |
| ▸ | MAPT | P10636 | 5/20 | 0.54 |
| ▸ | MEN1 | O00255 | 5/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.54 |
| ▸ | GMNN | O75496 | 3/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.54 |
| ▸ | TP53 | P04637 | 3/20 | 0.54 |
| ▸ | TSHR | P16473 | 3/20 | 0.54 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.54 |
| ▸ | BLM | P54132 | 2/20 | 0.54 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.54 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.54 |
| ▸ | GLA | P06280 | 1/20 | 0.52 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21877811 | 1.00 | LMNA (0.60) | LMNASMN1; SMN2CYP1A2MAPTMEN1 | |
| SCHEMBL21877806 | 1.00 | LMNA (0.60) | LMNASMN1; SMN2CYP1A2MAPTMEN1 | |
| SCHEMBL17165611 | 0.93 | LMNA (0.53) | LMNASMN1; SMN2CYP1A2MAPTMEN1 | |
| SCHEMBL22413247 | 0.87 | LMNA (0.60) | LMNASMN1; SMN2CYP1A2MAPTMEN1 | |
| SCHEMBL235232 | 0.85 | MEN1 (0.64) | LMNASMN1; SMN2CYP1A2MAPTMEN1 | |
| SCHEMBL9445136 | 0.85 | MEN1 (0.64) | LMNASMN1; SMN2CYP1A2MAPTMEN1 | |
| SCHEMBL25099265 | 0.84 | LMNA (0.66) | LMNASMN1; SMN2CYP1A2MAPTMEN1 | |
| SCHEMBL12137159 | 0.84 | LMNA (0.66) | LMNASMN1; SMN2CYP1A2MAPTMEN1 | |
| SCHEMBL12152164 | 0.84 | LMNA (0.66) | LMNASMN1; SMN2CYP1A2MAPTMEN1 | |
| SCHEMBL20530318 | 0.83 | LMNA (0.64) | LMNASMN1; SMN2CYP1A2MAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120092177-A | Sensor, kit and method for detecting biomarkers in saliva | 索科普哈应用研究产品商业化基因科学有限合伙公司 | 2025-06-03 | — | — | CN | claimed |
| CN-109563127-B | Compounds, agents and uses thereof | 麦特博隆股份有限公司 | 2024-01-05 | — | — | CN | claimed |
| EP-3855944-A1 | METHOD AND COMPOSITION FOR INCREASING THE BIOAVAILABILITY OF CARNITINE | Lonza Consumer Health Inc. (US) | 2021-08-04 | — | — | EP | claimed |
| CN-106537145-B | Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment | 麦特博隆股份有限公司 | 2020-08-25 | — | — | CN | claimed |
| CN-111406216-A | Compounds, reagents and uses thereof | 麦特博隆股份有限公司 | 2020-07-10 | — | — | CN | claimed |
| CN-111175398-A | Kit for diagnosing gout and application thereof | 广州丹晨医疗科技有限公司 | 2020-05-19 | — | — | CN | claimed |
| US-20200129464-A1 | Method and Composition for Increasing the Bioavailability of Carnitine | LONZA INC. | 2020-04-30 | — | — | US | claimed |
| CN-110196335-A | Biomarker relevant to renal function and its application method | 梅塔博隆股份有限公司 | 2019-09-03 | — | — | CN | claimed |
| CN-105209909-B | Biomarkers associated with renal function and methods of use thereof | 梅塔博隆股份有限公司 | 2019-06-07 | — | — | CN | claimed |
| CN-109414109-A | Method for sampling gums metabolin | 宝洁公司 | 2019-03-01 | — | — | CN | claimed |
| CN-102597762-B | Marker for determination of sensitivity to anticancer agent | 学校法人庆应义塾 | 2016-08-03 | — | — | CN | claimed |
| CN-102597762-A | Marker for determination of sensitivity to anticancer agent | UNIV KEIO | 2012-07-18 | — | — | CN | claimed |
| US-20260060948-A1 | METHODS FOR TREATING LIVER DISEASE | CYMABAY THERAPEUTICS INC (US) | 2026-03-05 | — | — | US | disclosed |
| CN-120092177-A | Sensor, kit and method for detecting biomarkers in saliva | 索科普哈应用研究产品商业化基因科学有限合伙公司 | 2025-06-03 | — | — | CN | disclosed |
| CN-119286971-A | Application of linoleoyl carnitine in screening of medicines with regulation effect on post-PCI proinflammatory phase prolongation of ACS patient, screening method and medicines | 天津中医药大学 | 2025-01-10 | — | — | CN | disclosed |
| CN-119224197-A | Method for analyzing amino acid and/or acyl carnitine | 株式会社岛津制作所 | 2024-12-31 | — | — | CN | disclosed |
| CN-106537145-A | Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment | 麦特博隆股份有限公司 | 2017-03-22 | — | — | CN | disclosed |
| CN-105891317-A | Anticancer Agent Sensitivity-Determining Marker | 学校法人庆应义塾 | 2016-08-24 | — | — | CN | disclosed |
| CN-102597762-B | Marker for determination of sensitivity to anticancer agent | 学校法人庆应义塾 | 2016-08-03 | — | — | CN | disclosed |
| CN-102597762-A | Marker for determination of sensitivity to anticancer agent | UNIV KEIO | 2012-07-18 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260060948-A1 | METHODS FOR TREATING LIVER DISEASE | SLC10A1, FABP1, HLA-A | LMNA 3235/4885SMN1; SMN2 1253/4885CYP1A2 699/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.